Skip to main content
photo of Adam S. Cheifetz, MD

Adam S. Cheifetz, MD

Contributor

Dr. Adam Cheifetz is director of the center for inflammatory bowel disease and medical director of infusion services at Beth Israel Deaconess Medical Center, and professor of medicine at Harvard Medical School. He is a well-recognized leader in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. He is involved in multiple research projects relating to IBD, and has published over 200 articles and chapters on the subject.

His research currently focuses on therapeutic drug monitoring and optimizing the use of biologics through the proactive use of drug concentrations and antibodies, and he has published extensively in this area. Dr. Cheifetz was the first to demonstrate that proactive monitoring of infliximab and adalimumab concentrations and dosing to a therapeutic window improves outcomes when compared to standard of care.

Harvard Health Publishing Logo

Thanks for visiting. Don't miss your FREE 32-page gift worth $29.95.

PLUS, don’t miss out on your 25% off promo code.

Sign up to get tips for living a healthy lifestyle—You’ll discover powerful, research- backed strategies for health longevity drawn from Harvard Medical School experts—ways to eat for a longer life, build strength and flexibility to stay independent, protect your bones, heart, and brain as you age, and even cultivate the habits linked with “super-agers” who stay sharp and active well into their 80s and 90s—all delivered to your email box FREE.

Harvard Health Publishing Logo

Stay on top of latest health news from Harvard Medical School.

Plus, get a FREE copy of Living Longer, Living Well!.

Harvard Health Publishing Logo

Stay on top of latest health news from Harvard Medical School.

Plus, get a FREE copy of Living Longer, Living Well.